Trial Profile
A Randomized Open Label Study Comparing the Efficacy, Safety and Tolerability of Oral Administration of Amantadine and Ribavirin and Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Amantadine/ribavirin (Primary) ; Oseltamivir
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 11 Jun 2012 Actual patient number is 2 according to ClinicalTrials.gov.
- 11 Jun 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 11 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.